CONVALIFE
Live / Allowed — Approved for publication (as of 16 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 03 Mar 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 79448644
- Mark type
- Design + words
- Filed
- 03 Mar 2026
- Attorney of record
- VICTORIA VELAZQUEZ WALKER
Goods and services
- Class 005 — Pharmaceuticals: Chemical preparations for pharmaceutical purposes for the treatment of cancers, viral infections, autoimmune diseases and inflammatory diseases; drugs for medical purposes for the treatment of cancers, viral infections, autoimmune diseases and inflammatory diseases; pharmaceutical preparations for the treatment of cancers, viral infections, autoimmune diseases and inflammatory diseases; chemico-pharmaceutical preparations for the treatment of cancers, viral infections, autoimmune diseases and inflammatory diseases; medicines for human purposes for the treatment of cancers, viral infections, autoimmune diseases and inflammatory diseases
Owner
Prosecution history
- 16 Oct 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Oct 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Oct 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 Oct 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 01 Oct 2026 — REFUSAL PROCESSED BY IB
- 11 Sept 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 10 Sept 2026 — REFUSAL PROCESSED BY MPU
- 26 Jun 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 25 Jun 2026 — NON-FINAL ACTION WRITTEN
- 16 Jun 2026 — ASSIGNED TO EXAMINER
- 24 Apr 2026 — APPLICATION FILING RECEIPT MAILED
- 24 Apr 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 23 Apr 2026 — SN ASSIGNED FOR SECT 66A APPL FROM IB